HER2 Positive Metastatic Breast Cancer

Details

Files
Project Status:
Complete
Therapeutic Area:
HER2 Positive Metastatic Breast Cancer
Project Line:
Reimbursement Review
Project Sub Line:
Provisional Funding Algorithm
Project Number:
PH0016-000

Review Type: Rapid

Provisional Funding Algorithm

Draft Report Posted:

November 17, 2022

Stakeholder Feedback Deadline:

November 24, 2022

Final Report Posted:

January 13, 2023